Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
TMP
Overvalued
TOMPKINS FINANCIAL CORP
Price$99.06
Model IV$77.75
P/IV1.11
Premium +27%
Return to IV: -21.5%
TMQ
Valuation N/A
Trilogy Metals Inc.
Price$3.27
Model IV—
P/IV—
Market implies +50.7%/yr
vs model +5.0% · above model
TMTS
Valuation N/A
Spartacus Acquisition Corp. II
Price$10.06
Model IV—
P/IV—
TMTSU
Valuation N/A
Spartacus Acquisition Corp. II
Price$10.30
Model IV—
P/IV—
TMUS
Undervalued
T-Mobile US, Inc.
Price$168.18
Model IV$212.01
P/IV0.86
Discount 21%
Return to IV: +26.1%
Owner yield 6.7%
10-yr IRR 9.4% · steady
Market implies -0.9%/yr
vs model +2.6% · below model
TMUSI
Deeply undervalued
T-Mobile US, Inc.
Price$18.92
Model IV$212.01
P/IV0.09
Discount 91%
Return to IV: +1,020.6%
Market implies -39.9%/yr
vs model +2.6% · below model
TMUSL
Deeply undervalued
T-Mobile US, Inc.
Price$21.79
Model IV$212.01
P/IV0.10
Discount 90%
Return to IV: +872.9%
Market implies -36.5%/yr
vs model +2.6% · below model
TMUSZ
Deeply undervalued
T-Mobile US, Inc.
Price$19.48
Model IV$212.01
P/IV0.09
Discount 91%
Return to IV: +988.3%
Market implies -39.2%/yr
vs model +2.6% · below model
TNC
Deeply overvalued
TENNANT CO
Price$68.68
Model IV$24.76
P/IV3.48
Premium +177%
Return to IV: -64.0%
Owner yield 7.3%
10-yr IRR 11.4% · steady
Market implies +15.9%/yr
vs model +3.5% · above model
TNDM
Fairly valued
TANDEM DIABETES CARE INC
Price$16.81
Model IV$17.19
P/IV1.00
Discount 2%
Return to IV: +2.2%
Market implies -1.7%/yr
vs model +9.6% · below model
TNET
Deeply undervalued
TRINET GROUP, INC.
Price$66.01
Model IV$76.03
P/IV0.14
Discount 13%
Return to IV: +15.2%
Owner yield 9.3%
10-yr IRR 20.2% · moderate
Market implies +4.7%/yr
vs model +9.4% · below model
TNGX
Valuation N/A
Tango Therapeutics, Inc.
Price$23.89
Model IV—
P/IV—
Market implies +46.9%/yr
vs model +13.9% · above model
TNK
Deeply undervalued
TEEKAY TANKERS LTD.
Price$100.83
Model IV$399.33
P/IV0.18
Discount 75%
Return to IV: +296.0%
Owner yield 10.9%
10-yr IRR 25.8% · grower
Market implies -7.8%/yr
vs model +12.4% · below model
TNL
Deeply undervalued
Travel & Leisure Co.
Price$66.74
Model IV$131.36
P/IV0.52
Discount 49%
Return to IV: +96.8%
Owner yield 8.8%
10-yr IRR 20.7% · moderate
Market implies -0.9%/yr
vs model +10.9% · below model
TNMG
Valuation N/A
TNL Mediagene
Price$3.36
Model IV—
P/IV—
TNON
Valuation N/A
Tenon Medical, Inc.
Price$5.93
Model IV—
P/IV—
TNXP
Valuation N/A
Tonix Pharmaceuticals Holding Corp.
Price$11.87
Model IV—
P/IV—
Market implies +47.7%/yr
vs model +15.0% · above model
TNYA
Valuation N/A
Tenaya Therapeutics, Inc.
Price$0.64
Model IV—
P/IV—
TOI
Deeply undervalued
Oncology Institute, Inc.
Price$6.20
Model IV$10.83
P/IV0.43
Discount 43%
Return to IV: +74.6%
Market implies -7.6%/yr
vs model +25.5% · below model
TOIIW
Valuation N/A
Oncology Institute, Inc.
Price$0.05
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +25.5% · below model
TOL
Undervalued
Toll Brothers, Inc.
Price$134.23
Model IV$181.12
P/IV0.76
Discount 26%
Return to IV: +34.9%
Owner yield 7.9%
10-yr IRR 17.8% · moderate
Market implies +3.7%/yr
vs model +9.8% · below model
TOMZ
Valuation N/A
TOMI Environmental Solutions, Inc.
Price$1.62
Model IV—
P/IV—
Market implies +29.7%/yr
vs model +0.0% · above model
TONX
Valuation N/A
TON Strategy Co
Price$3.04
Model IV—
P/IV—
Market implies +89.7%/yr
vs model +5.0% · above model
TOON
Deeply undervalued
Kartoon Studios, Inc.
Price$0.61
Model IV$4.20
P/IV0.17
Discount 86%
Return to IV: +593.1%
Market implies -40.6%/yr
vs model +49.5% · below model
TOP
Valuation N/A
TOP Financial Group Ltd
Price$14.88
Model IV—
P/IV—
Market implies +87.7%/yr
vs model +2.0% · above model
TOPP
Valuation N/A
Toppoint Holdings Inc.
Price$0.16
Model IV—
P/IV—
Market implies -20.3%/yr
vs model +2.0% · below model
TOPS
Valuation N/A
TOP SHIPS INC.
Price$0.72
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +15.4% · below model
TORO
Valuation N/A
TORO CORP.
Price$6.42
Model IV—
P/IV—
Market implies +70.7%/yr
vs model +15.0% · above model
TOST
Fairly valued
Toast, Inc.
Price$32.12
Model IV$23.17
P/IV1.12
Premium +39%
Return to IV: -27.9%
Market implies +23.6%/yr
vs model +25.0% · in line
TOUR
Valuation N/A
Tuniu Corp
Price$5.11
Model IV—
P/IV—
Market implies +48.6%/yr
vs model +5.4% · above model
TOVX
Valuation N/A
Theriva Biologics, Inc.
Price$0.25
Model IV—
P/IV—
TOXR
Deeply overvalued
21Shares XRP ETF
Price$13.29
Model IV$8.70
P/IV1.48
Premium +53%
Return to IV: -34.5%
TOYO
Deeply undervalued
TOYO Co., Ltd
Price$4.40
Model IV$28.60
P/IV0.51
Discount 85%
Return to IV: +549.9%
Market implies -15.3%/yr
vs model +16.0% · below model
TPB
Deeply overvalued
Turning Point Brands, Inc.
Price$72.17
Model IV$44.62
P/IV1.90
Premium +62%
Return to IV: -38.2%
Owner yield 4.1%
10-yr IRR 6.3% · moderate
Market implies +11.0%/yr
vs model +7.0% · above model
TPC
Fairly valued
TUTOR PERINI CORP
Price$84.51
Model IV$79.44
P/IV0.90
Premium +6%
Return to IV: -6.0%
Owner yield 9.5%
10-yr IRR 16.9% · steady
Market implies +5.2%/yr
vs model +5.0% · in line
TPCS
Undervalued
TECHPRECISION CORP
Price$5.77
Model IV$5.53
P/IV0.72
Premium +4%
Return to IV: -4.2%
Market implies -7.9%/yr
vs model +21.5% · below model
TPET
Valuation N/A
Trio Petroleum Corp
Price$1.97
Model IV—
P/IV—
Market implies +32.3%/yr
vs model +8.0% · above model
TPG
Deeply overvalued
TPG Inc.
Price$47.69
Model IV$16.07
P/IV2.65
Premium +197%
Return to IV: -66.3%
Market implies +31.2%/yr
vs model +20.2% · above model
TPGXL
Deeply undervalued
TPG Inc.
Price$21.54
Model IV$35.04
P/IV0.69
Discount 39%
Return to IV: +62.7%
Market implies +9.0%/yr
vs model +20.2% · below model
TPL
Valuation N/A
Texas Pacific Land Corp
Price$352.67
Model IV—
P/IV—
TPR
Deeply overvalued
TAPESTRY, INC.
Price$115.00
Model IV$66.98
P/IV2.17
Premium +72%
Return to IV: -41.8%
Owner yield 4.0%
10-yr IRR 7.9% · moderate
Market implies +16.1%/yr
vs model +10.0% · above model
TPST
Valuation N/A
Tempest Therapeutics, Inc.
Price$0.81
Model IV—
P/IV—
TPTA
Deeply overvalued
Terra Property Trust, Inc.
Price$24.73
Model IV$6.11
P/IV3.73
Premium +305%
Return to IV: -75.3%
TPVG
Valuation N/A
TriplePoint Venture Growth BDC Corp.
Price$5.16
Model IV—
P/IV—
TR
Fairly valued
TOOTSIE ROLL INDUSTRIES INC
Price$38.89
Model IV$43.38
P/IV0.87
Discount 10%
Return to IV: +11.5%
Owner yield 3.4%
10-yr IRR 2.9% · moderate
Market implies +3.7%/yr
vs model +6.0% · in line
TRAD
Valuation N/A
APEX Tech Acquisition Inc.
Price$10.02
Model IV—
P/IV—
TRAK
Deeply overvalued
ReposiTrak, Inc.
Price$8.31
Model IV$5.44
P/IV1.90
Premium +53%
Return to IV: -34.5%
Owner yield 5.0%
10-yr IRR 7.9% · steady
Market implies +8.4%/yr
vs model +5.7% · in line
TRAW
Deeply undervalued
Traws Pharma, Inc.
Price$0.56
Model IV$1.16
P/IV1.26
Discount 51%
Return to IV: +104.7%
Market implies -13.3%/yr
vs model +50.0% · below model
TRAX
Valuation N/A
First Tracks Biotherapeutics, Inc.
Price$36.44
Model IV—
P/IV—
TRC
Deeply overvalued
TEJON RANCH CO
Price$16.21
Model IV$6.72
P/IV2.87
Premium +141%
Return to IV: -58.5%
Market implies +3.0%/yr
vs model +15.0% · below model
TRDA
Valuation N/A
Entrada Therapeutics, Inc.
Price$6.80
Model IV—
P/IV—
Market implies +34.2%/yr
vs model +15.0% · above model
TREE
Deeply overvalued
LendingTree, Inc.
Price$26.82
Model IV$21.07
P/IV1.81
Premium +27%
Return to IV: -21.4%
Market implies +5.2%/yr
vs model +3.0% · in line
TREX
Deeply overvalued
TREX CO INC
Price$43.66
Model IV$10.53
P/IV3.93
Premium +315%
Return to IV: -75.9%
Owner yield 1.9%
10-yr IRR -5.6% · steady
Market implies +23.1%/yr
vs model +3.0% · above model
TRGP
Deeply overvalued
Targa Resources Corp.
Price$292.19
Model IV$184.20
P/IV1.38
Premium +59%
Return to IV: -37.0%
TRGS
Valuation N/A
TRG Latin America Acquisitions Corp.
Price$10.03
Model IV—
P/IV—
TRGSR
Valuation N/A
TRG Latin America Acquisitions Corp.
Price$0.17
Model IV—
P/IV—
TRI
Valuation N/A
THOMSON REUTERS CORP /CAN/
Price$97.35
Model IV—
P/IV—
TRIB
Valuation N/A
TRINITY BIOTECH PLC
Price$7.74
Model IV—
P/IV—
TRIN
Valuation N/A
Trinity Capital Inc.
Price$17.93
Model IV—
P/IV—
TRINI
Valuation N/A
Trinity Capital Inc.
Price$25.39
Model IV—
P/IV—
